Literature DB >> 6972410

Modulation of granulomatous hypersensitivity. II. Participation of Ly 1+ and Ly 2+ T lymphocytes in the suppression of granuloma formation and lymphokine production in Schistosoma mansoni-infected mice.

S W Chensue, S R Wellhausen, D L Boros.   

Abstract

The regulatory mechanism(s) active in the spontaneous suppression of parasite egg-induced granulomatous response was analyzed in Schistosoma mansoni-infected mice. A single injection of cyclophosphamide (CY) given to chronically infected mice with diminished granulomas and impaired ability to produce MIF restored the enhanced granulomatous response and lymphokine production by spleen cells. Drug-treated animals also showed a rise in the level of circulating anti-egg antigen antibody. After CY treatment, spleen cells were still capable of adoptively suppressing the vigorous granulomatous response and MIF production in acutely infected recipients. Adoptive suppression, however, was abrogated when spleen cells of chronically infected mice were pretreated with anti-Lyt 1.1 alloantiserum and C before transfer. Based on the present and previous observations, it is proposed that the modulated granulomatous inflammatory response in mice with chronic infection is maintained by a dynamic equilibrium between effector and regulator lymphocytes. Although the inflammation is maintained by Ly 1+ Ia- TDH cells, the intensity of the response is regulated by Ly 1+ Ia+ TH, Ly 2+ Ia+ Ts and possibly a putative precursor population of lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6972410

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  40 in total

1.  Tissue reactions induced by hydrocolloid wound dressings.

Authors:  M D Leek; Y M Barlow
Journal:  J Anat       Date:  1992-06       Impact factor: 2.610

2.  Schistosomal egg antigen-responsive CD8 T-cell population in Schistosoma mansoni-infected BALB/c mice.

Authors:  V Pancré; M Delacre; J Herno; C Auriault
Journal:  Immunology       Date:  1999-12       Impact factor: 7.397

3.  Immune responses during human Schistosomiasis mansoni. Evidence for antiidiotypic T lymphocyte responsiveness.

Authors:  M S Lima; G Gazzinelli; E Nascimento; J C Parra; M A Montesano; D G Colley
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

4.  The T-cell mediated immune response to Schistosoma mansoni. I. Generation of stage-specific, MHC-restricted proliferative T-cell clones to soluble egg antigens.

Authors:  N K Mak; C J Sanderson
Journal:  Immunology       Date:  1985-04       Impact factor: 7.397

5.  Retroviral Foxp3 gene transfer ameliorates liver granuloma pathology in Schistosoma mansoni infected mice.

Authors:  Kameshwar P Singh; Herve C Gerard; Alan P Hudson; Thipparthi R Reddy; Dov L Boros
Journal:  Immunology       Date:  2005-03       Impact factor: 7.397

6.  Schistosoma japonicum egg antigen-specific T cell lines in man. Induction of helper and suppressor T cell lines and clones in vitro in a patient with chronic schistosomiasis japonica.

Authors:  N Ohta; T Itagaki; M Minai; K Hirayama; Y Hosaka
Journal:  J Clin Invest       Date:  1988-03       Impact factor: 14.808

7.  Unimpaired down-modulation of the hepatic granulomatous response in CD8 T-cell- and gamma interferon-deficient mice chronically infected with Schistosoma mansoni.

Authors:  G Yap; A Cheever; P Caspar; D Jankovic; A Sher
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

8.  Mechanisms associated with immunoregulation in human American cutaneous leishmaniasis.

Authors:  M Castés; A Agnelli; A J Rondón
Journal:  Clin Exp Immunol       Date:  1984-08       Impact factor: 4.330

9.  Role of lipoxygenase products in murine pulmonary granuloma formation.

Authors:  S L Kunkel; S W Chensue; C Mouton; G I Higashi
Journal:  J Clin Invest       Date:  1984-08       Impact factor: 14.808

10.  Splenic and granuloma T-lymphocyte responses to fractionated soluble egg antigens of Schistosoma mansoni-infected mice.

Authors:  N W Lukacs; D L Boros
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.